FastTRK is a clinical testing program for the diagnosis of NTRK gene fusions. Funded by Bayer Inc., this is a complimentary service for clinicians to determine whether their patients’ cancer has an NTRK gene fusion. Click here for more information.
ATTENTION TRAVELLERS: FlyClear™ by LifeLabs migrated to a new portal on December 14, 2021.
If you are looking to register for travel-related COVID testing or access your FlyClear results, here.